1. Intracerebral haemorrhage profiles are changing: results from the Dijon population-based study / Y. Béjot [et al.] // Brain. – 2013. – Vol. 136, N 2. – P. 658–664. https://doi.org/10.1093/brain/aws349

2. Крылов, В. В. Патогенез сосудистого спазма и ишемии головного мозга при нетравматическом субарахноидальном кровоизлиянии вследствие разрыва церебральных аневризм / В. В. Крылов, А. А. Калинкин, С. С. Петриков // Невролог. журн. – 2014. – Т. 19, № 5. – С. 4–12.

3. Vascular disruption and blood-brain barrier dysfunction in intracerebral hemorrhage / R. F. Keep [et al.] // Fluids Barriers CNS. – 2014. – Vol. 11, N 1. – Art. 18. https://doi.org/10.1186/2045-8118-11-18

4. Delayed clot removal and experimental vasospasm / Z. D. Zhang [et al.] // Acta Neurochir. Suppl. – 2001. – Vol. 77. – P. 33–35. https://doi.org/10.1007/978-3-7091-6232-3_8

5. Fisher, C. M. Relation of cerebral vasospasm to subarachnoid hemorrage visualized by computerized tomographic scanning / C. M. Fisher,J. P. Kistler,J. M. Davis// Neurosurgery. – 1980. – Vol. 6, N 1. – P. 1–9. https://doi.org/10.1227/00006123-198001000-00001

6. Mishizawa, S. Signaling mechanisms in cerebral vasospasm / S. Mishizawa, I. Laher // Trends Cardiovasc. Med. – 2005. – Vol. 15, N 1. – P. 24–34. https://doi.org/10.1016/j.tcm.2004.12.002

7. Macdonald, R. L. Cerebral vasospasm and free radicals / R. L. Macdonald, B. K. Weir // Free Radic. Biol. Med. – 1994. – Vol. 16, N 5. – P. 633–643. https://doi.org/10.1016/0891-5849(94)90064-7

8. Increased levels of plasma cholesteryl ester hydroperoxides in patients with subarachnoid hemorrhage / M. C. Polidon [et al.] // Free Radic. Biol. Med. – 1997. – Vol. 23, N 5. – P. 762–767. https://doi.org/10.1016/s0891-5849(97)00053-1

9. Kolias, A. G. Pathogenesis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage putative mechanisms and novel approaches / A. G. Kolias, J. Sen, A. Belli // J. Neurosci. Res. – 2009. – Vol. 87, N 1. – P. 1–11. https://doi.org/10.1002/jnr.21823

10. Cerebrospinal fluid nitrite/nitrate correlated with oxyhemoglobin and outcome in patients with subarachnoid hemorrhage / K. Rejdak [et al.] // J. Neurol. Sci. – 2004. – Vol. 219, N 1–2. – P. 71–76. https://doi.org/10.1016/j.jns.2003.12.011

11. Phosphodiesterase 5 inhibition attenuates cerebral vasospasm and improves functional recovery after experimental subarachnoid hemorrhage / B. H. Han [et al.] // Neurosurgery. – 2012. – Vol. 70, N 1. – P. 178–187. https://doi.org/10.1227/neu.0b013e31822ec2b0

12. Saccular intracranial aneurysm: pathology and mechanisms / J. Frösen [et al.] // Acta Neuropathol. – 2012. – Vol. 123, N 6. – P. 773–786. https://doi.org/10.1007/s00401-011-0939-3

13. Фатеева, В. В. Маркеры эндотелиальной дисфункции при хронической ишемии мозга / В. В. Фатеева, О. В. Воробьева // Журн. неврол. и психиатр. – 2017. – № 4. – С. 107–111.

14. Inflammation in intracerebral hemorrhage: from mechanisms to clinical translation / Y. Zhou [et al.] // Prog. Neurobiol. – 2014. – Vol. 115. – P. 25–44. https://doi.org/10.1016/j.pneurobio.2013.11.003

15. The blood leukocyte count and its prognostic significance in subarachnoid hemorrhage / F. Maiuri [et al.] // J. Neurosurg. Sci. – 1987. – Vol. 31, N 2. – P. 45–48.

16. Cisternal CSF levels of cytokines after subarachnoid hemorrhage / P. Gaetani [et al.] // Neurol. Res. – 1998. – Vol. 20, N 4. – P. 337–342. https://doi.org/10.1080/01616412.1998.11740528

17. Compartmentalisation of the inflammatory response following aneurysmal subarachnoid haemorrhage / Y. Z. Al-Tamimi [et al.] // Cytokine. – 2019. – Vol. 123. – P. 154778. https://doi.org/10.1016/j.cyto.2019.154778

18. Role magnesium in the reduction of ischemic depolarization and lesion volum after experimental subarachnoid hemorrhage / W. M. van Den Berg [et al.] // J. Neurosurg. – 2002. – Vol. 97, N 2. – P. 416–422. https://doi.org/10.3171/jns.2002.97.2.0416

19. Guidelines for the early management of adults with ischemic stroke: a guideline from the AHA/ASA Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vasrular Disease and Quality of Care Outcomes in Research Interdiscriplinary Working Groups / H. P. Adams [et al.] // American Academy of Neurology affirms the value of this guideline as on educational tool for neurologists. – 2007. – Vol. 115, N 20. – P. 478–534. https://doi.org/10.1161/circulationaha.107.181486

20. Feng, D. F. Effects of magnesium sulfate on traumatic brain edema in rats / D. F. Feng, Z. A. Zhu, Y. C. Lu // Chin. J. Traumatol. – 2004. – Vol. 7, N 3. – P. 148–152.

21. Magnesium sulfate in the management of patients with aneurysmal subarachnoid hemorrhage: a randomized, placebocontrolled, dose-adapted trial / C. Muroi [et al.] // Surg. Neurol. – 2008. – Vol. 69, N 1. – P. 33–39. https://doi.org/10.1016/j.surneu.2007.07.015

22. Magnesium sulfate: role as possible attenuating factor in vasospasm morbidity / D. M.-S. Prevedello [et al.] // Surg. Neurol. – 2006. – Vol. 65. – P. S14–S20. https://doi.org/10.1016/j.surneu.2005.11.035

23. Костюк, В. А. Определение продуктов перекисного окисления липидов с помощью тиобарбитуровой кислоты в анаэробных условиях / В. А. Костюк, А. И. Потапович // Вопр. мед. химии. – 1987. – Т. 33, № 3. – С. 115–118.

24. Костюк, В. А. Простой и чувствительный метод определения активности супероксиддисмутазы, основанный на реакции окисления кверцетина / В. А. Костюк, А. И. Потапович, Ж. В. Ковалева // Вопр. мед. химии. – 1990. – Т. 36, № 2. – С. 88–91.

25. Pluta, R. M. Analysis of nitric oxide (NO) in cerebral vasospasm after aneursymal bleeding / R. M. Pluta, E. H. Oldfield // Rev. Recent Clin. Trials. – 2007. – Vol. 2, N 1. – P. 59–67. https://doi.org/10.2174/157488707779318062

26. Coleman, H. A. Endothelial potassium channels, endothelium-dependent hyperpolarization and the regulation of vascular tone in health and disease / H. A. Coleman, T. Mare, H. C. Parkington // Clin. Exp. Pharmacol. Physiol. – 2004. – Vol. 31, N 9. – P. 641–649. https://doi.org/10.1111/j.1440-1681.2004.04053.x

27. Мазуров, В. И. Эндотелиальная дисфункция при метаболическом синдроме / В. И. Мазуров, В. А. Якушева // Эфферент. терапия. – 2006. – Т. 12, № 3. – С. 19–24.

28. Moncada, S. Nitric oxide and oxygen: actions and interactions in health and disease / P. S. Moncada // Redox Biol. – 2015. – Vol. 5. – P. 421. https://doi.org/10.1016/j.redox.2015.09.034